Biotech stocks are experiencing significant moves in pre-market activity on Monday, indicating potential trading opportunities.
By evaluating sentiment and momentum before the bell, pre-market analysis becomes a foundational step in any trader's pre-market routine.
In the Green - Premarket Gainers-On Monday, the following stocks are trading significantly higher in the premarket session,
1. Avidity Biosciences Inc. (RNA) - up 44% at $70.652. Dyne Therapeutics Inc. (DYN) - up 36% at $23.203. PepGen Inc. (PEPG) - up 17% at $5.354. Semler Scientific Inc. (SMLR) - up 14% at $27.325. Relmada Therapeutics Inc. (RLMD) - up 11% at $2.346. Milestone Scientific Inc. (MLSS) - up 11% at $0.467. Dyadic International Inc. (DYAI) - up 10% at $1.258. Neumora Therapeutics Inc. (NMRA) - up 10% at $2.899. EUDA Health Holdings Ltd. (EUDA) - up 9% at $2.5810. BridgeBio Pharma Inc. (BBIO) - up 9% at $58.90
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.